Job Watch
Notice to Extend the Expiration Date for PAR-15-349 "Health Disparities and Alzheimer's Disease (R01)"
Notice NOT-AG-18-016 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Extramural Loan Repayment Program for Pediatric Research (LRP-PR)
Notice NOT-OD-18-200 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
Notice NOT-OD-18-201 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
Notice NOT-OD-18-199 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Notice NOT-OD-18-198 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Funding Opportunity PAR-18-840 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for the Global Infectious Disease (GID) Research Training Program from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of an LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-infections in HIV infected individuals or infections associated with non-communicable disease conditions of public health importance in LMICs
Categories: Job Watch, Literature Watch
Notice of Change to Application Types Allowed in PA-17-239 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)"
Notice NOT-CA-18-080 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIDA Division of Neuroscience and Behavior Will Give High Programmatic Priority to Opioid Related Basic Research
Notice NOT-DA-18-015 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Administrative Supplements for Basic Research on Opioids to Existing Grant Awards
Notice NOT-DA-18-014 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Paramount Recruitment: Web Developer
Negotiable:
Paramount Recruitment:
Web Developer
Genomics/Bioinformatics - Cambridge - Permanent
Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 Genomes Project.
Cambridge, England
Categories: Job Watch
Paramount Recruitment: Bioinformatic Software Developer - (Python, Perl, R)
Negotiable:
Paramount Recruitment:
Bioinformatic Software Developer - Stevenage (Python, Perl, R)
A new opportunity has recently become available for a talented Software Engineer to work with a growing Biotech company based in Stevenage.
Stevenage, England
Categories: Job Watch
Programmer Analyst II - Medical College of Wisconsin - Milwaukee, WI
Design, code, test, debug, modify, and document applications for use in basic science research and genomic analysis in a cost-effective and efficient manner...
From Medical College of Wisconsin - Mon, 25 Jun 2018 15:07:39 GMT - View all Milwaukee, WI jobs
From Medical College of Wisconsin - Mon, 25 Jun 2018 15:07:39 GMT - View all Milwaukee, WI jobs
Categories: Job Watch
NIA AD/ADRD Health Care Systems Research Collaboratory (U54 - Clinical Trial Required)
Funding Opportunity RFA-AG-19-009 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the AD/ADRD Health Care Systems Research Collaboratory (Collaboratory, henceforth) to improve care for persons with dementia (PWD) and their caregivers through health systems. Health and long-term systems for this FOA are defined broadly and include organizations providing care across settings to include primary and specialty outpatient care, acute inpatient care, skilled nursing and other rehabilitation facilities, residential long-term care, and home and community-based services. Organizations may be traditional health care systems (e.g., health maintenance organizations, or HMOs), health insurance companies, managed care plans, home health care providers, memory clinics, nursing homes, assisted living facilities, outpatient clinics, federally-designated health centers, hospitals, and other providers of acute and long-term care. The Collaboratory will: 1) serve as a national resource to promote development of pragmatic trials and demonstration projects to improve care and health outcomes for PWD and their caregivers; 2) support pilot pragmatic trials within the Collaboratory; 3) develop and disseminate technical and policy guidelines and best practices for effectively conducting AD/ADRD research studies in partnership with health care systems; 4) work collaboratively with researchers to provide technical support for scaling up pilot studies, and; 5) disseminate best practices for engaging stakeholders, conducting ethical research in the special circumstances of dementia care, and involving long-term and acute-care providers.
Categories: Job Watch, Literature Watch
Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)
Funding Opportunity RFA-CA-18-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to support the Cooperative Human Tissue Network (CHTN). The goal for CHTN is to collect and distribute high quality human tissue specimens to facilitate basic and early translational cancer research, as well as assay development. The CHTN is designed as a unique biospecimen resource in that it is based on prospective collection and distribution of samples upon specific investigators requests. Samples to be collected from patients include pre-cancerous, cancerous, and benign neoplastic tissues, as well as specimens corresponding to non-neoplastic diseases and uninvolved tissues. This FOA solicits applications for CHTN awards from institutions/teams capable of contributing to the mission of CHTN by: (1) providing prospective investigator-defined procurement of high-quality malignant, benign, diseased, and uninvolved (normal adjacent) tissues and fluids from patients throughout North America and elsewhere; (2) assisting individual investigators with regard to specific specimen needs of their research; (3) assisting in developing and disseminating knowledge on high quality practices for successfully operating a biospecimen repository; and (4) educating the community about the importance of the availability of high quality human tissue specimens for medical research. Depending on their profile and capabilities, applicants must indicate whether they propose to function as the CHTN adult biospecimen division or the pediatric specimen division. Nonetheless, it will be acceptable for an adult biospecimen division, if capable, to contribute pediatric samples for networked requests. This FOA is open to all qualified applicants irrespective of their previous association with the CHTN.
Categories: Job Watch, Literature Watch
Clarification: Assignment Deadlines for Applications Submitted Under the NIH Continuous Submission Policy
Notice NOT-OD-18-178 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-022 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)"
Notice NOT-NS-18-066 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System"
Notice NOT-NS-18-067 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-021 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)"
Notice NOT-NS-18-065 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-012 "Translational Neural Devices (U44 Clinical Trial Required)"
Notice NOT-NS-18-064 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Clarification for Submission of Materials Related to Communications with the FDA for RFA-NS-18-011 "Translational Neural Devices (UG3/UH3 Clinical Trial Required)"
Notice NOT-NS-18-063 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Pages
